ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for alerts 실시간 알림, 사용자 정의 포트폴리오 및 시장 동향을 받으려면 등록하세요.

MTEM Molecular Templates Inc

1.725
0.075 (4.55%)
03 5월(5) 2024 - 마감
15분 지연
기업명 주식 심볼 시장 주식 타입
Molecular Templates Inc MTEM 나스닥 보통주
  가격 변동 가격 변동 % 주식 가격 최근 거래 시간
0.075 4.55% 1.725 08:50:01
개장가 저가 고가 종가 전일 종가
1.64 1.55 1.725 1.725 1.65
시세 정보 더보기 »

최근 뉴스

일자 시간 출처 제목
09/04/202421:11GLOBEMolecular Templates Presents Interim Data from MT-6402 Phase..
29/03/202421:21GLOBEMolecular Templates, Inc. Reports Fourth Quarter 2023..
28/03/202421:11GLOBEMolecular Templates Announces $9.5 Million Private Placement..
04/03/202422:11GLOBEMolecular Templates, Inc. Provides Interim Update
15/02/202410:39EDGAR2Form SC 13G - Statement of acquisition of beneficial..
15/02/202406:45EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
09/02/202407:55GLOBEMolecular Templates to Present at Oppenheimer 34th Annual..
26/01/202407:49EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/01/202407:34EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/01/202407:32EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/01/202406:04EDGAR2Form 8-K - Current report
14/11/202306:13EDGAR2Form 8-K - Current report
14/11/202306:12EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
14/11/202306:11GLOBEMolecular Templates, Inc. Reports Third Quarter 2023..
03/11/202305:11GLOBEMolecular Templates Announces First Patient Dosed in Phase 1..
02/11/202305:14EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/11/202305:12GLOBEMolecular Templates to Participate in Upcoming Investor..
01/11/202307:46EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/11/202307:46EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/11/202307:46EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/11/202307:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/11/202307:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/11/202307:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/10/202305:12EDGAR2Form 8-K - Current report
07/10/202306:08EDGAR2Form 3 - Initial statement of beneficial ownership of..
29/09/202306:01EDGAR2Form 8-K - Current report
29/09/202305:11GLOBEMolecular Templates Announces the Appointment of Dr...
13/09/202306:15EDGAR2Form ARS - Annual Report to Security Holders
13/09/202306:12EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
13/09/202306:08EDGAR2Form DEF 14A - Other definitive proxy statements
01/09/202307:22EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/09/202305:11EDGAR2Form 8-K - Current report
12/08/202305:12EDGAR2Form 8-K - Current report
12/08/202300:22GLOBEMolecular Templates Announces 1-for-15 Reverse Stock Split
10/08/202322:01EDGAR2Form S-3 - Registration statement under Securities Act of..
10/08/202321:18EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
10/08/202321:09EDGAR2Form 8-K - Current report
10/08/202321:08GLOBEMolecular Templates, Inc. Reports Second Quarter 2023..
03/08/202305:16EDGAR2Form 8-K - Current report
03/08/202305:11GLOBEMolecular Templates Announces Executive Leadership Changes
19/07/202300:56EDGAR2Form DEF 14A - Other definitive proxy statements
14/07/202301:48EDGAR2Form 8-K - Current report
13/07/202321:14GLOBEMolecular Templates Announces Up to $40 Million Private..
01/07/202305:31EDGAR2Form PRE 14A - Other preliminary proxy statements
17/06/202309:56GLOBEMolecular Templates Announces Debt Payoff and Restructuring
01/06/202320:57GLOBEMolecular Templates Announces the FDA Removal of Partial..
27/05/202306:10GLOBEMolecular Templates to Present on Phase I Dose Escalation..
16/05/202305:13GLOBEMolecular Templates, Inc. Reports First Quarter 2023..

최근 히스토리

Delayed Upgrade Clock